CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $389 | -28.0% | 17,818 | +4.8% | 0.00% | -25.0% |
| Q2 2023 | $540 | +14.9% | 17,000 | -11.7% | 0.00% | +33.3% |
| Q1 2023 | $470 | -20.7% | 19,263 | +2.4% | 0.00% | -25.0% |
| Q4 2022 | $593 | -99.9% | 18,808 | -3.2% | 0.00% | 0.0% |
| Q3 2022 | $549,000 | +123.2% | 19,432 | +109.1% | 0.00% | +100.0% |
| Q2 2022 | $246,000 | -23.4% | 9,292 | +1.5% | 0.00% | 0.0% |
| Q1 2022 | $321,000 | +18.5% | 9,159 | +9.5% | 0.00% | +100.0% |
| Q4 2021 | $271,000 | +34.2% | 8,364 | +22.4% | 0.00% | 0.0% |
| Q3 2021 | $202,000 | – | 6,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,912,345 | 41.46% |
| Perceptive Advisors | 6,511,727 | $205,379,869 | 5.77% |
| Finepoint Capital LP | 517,287 | $16,315 | 5.28% |
| Artal Group S.A. | 1,900,000 | $59,926 | 3.34% |
| Affinity Asset Advisors, LLC | 215,000 | $6,781,100 | 2.66% |
| Rock Springs Capital Management LP | 2,506,464 | $79,053,875 | 1.90% |
| Hood River Capital Management LLC | 923,638 | $29,131,543 | 1.06% |
| Logos Global Management LP | 260,000 | $8,200,400 | 0.96% |
| Frazier Life Sciences Management, L.P. | 393,000 | $12,395,220 | 0.77% |
| FEDERATED HERMES, INC. | 2,867,451 | $90,439,405 | 0.25% |